Literature DB >> 12209628

Gelatinase B deficiency protects against endotoxin shock.

Bénédicte Dubois1, Sofie Starckx, Axel Pagenstecher, Joost van den Oord, Bernd Arnold, Ghislain Opdenakker.   

Abstract

Gelatinase B or matrix metalloproteinase-9 (MMP-9) is stored in the tertiary granules of polymorphonuclear leukocytes. These cells are key effectors in acute inflammatory diseases such as sepsis. Endotoxin leads to rapid release of gelatinase B from these granules in vitro and in vivo, but the role of this enzyme in bacterial sepsis and endotoxin shock remains unclear. We studied the clinical course of endotoxinemia and its relation with the expression of gelatinase B from the pool of circulating leukocytes in adult as well as in young mice in a model of endotoxin-induced shock and compared wild-type with gelatinase B-deficient mice. The gelatinase B-deficient mice were resistant to endotoxin shock, which implies that specific MMP-9 inhibition constitutes anapproach for the treatment of septic shock syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209628     DOI: 10.1002/1521-4141(200208)32:8<2163::AID-IMMU2163>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  The paradox of matrix metalloproteinases in infectious disease.

Authors:  P T G Elkington; C M O'Kane; J S Friedland
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 2.  Matrix metalloproteinases as modulators of inflammation.

Authors:  Anne M Manicone; John K McGuire
Journal:  Semin Cell Dev Biol       Date:  2007-07-10       Impact factor: 7.727

3.  Role of the pulmonary epithelium and inflammatory signals in acute lung injury.

Authors:  Anne M Manicone
Journal:  Expert Rev Clin Immunol       Date:  2009-01-01       Impact factor: 4.473

Review 4.  Infections in myelodysplastic syndromes.

Authors:  Andréa Toma; Pierre Fenaux; François Dreyfus; Catherine Cordonnier
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

5.  Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism.

Authors:  Elisabeth Elass; Laëtitia Aubry; Maryse Masson; Agnès Denys; Yann Guérardel; Emmanuel Maes; Dominique Legrand; Joël Mazurier; Laurent Kremer
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.

Authors:  M M Lalu; J Cena; R Chowdhury; A Lam; R Schulz
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

7.  Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat.

Authors:  Henrique S Rosário; Stephen W Waldo; Scott A Becker; Geert W Schmid-Schönbein
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

8.  CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.

Authors:  Ebbe Billmann Thorgersen; Bernt Christian Hellerud; Erik Waage Nielsen; Andreas Barratt-Due; Hilde Fure; Julie Katrine Lindstad; Anne Pharo; Erik Fosse; Tor Inge Tønnessen; Harald Thidemann Johansen; Albert Castellheim; Tom Eirik Mollnes
Journal:  FASEB J       Date:  2009-10-19       Impact factor: 5.191

Review 9.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

Authors:  Leonardo Lorente; María M Martín; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Blanquer; Josune Orbe; José A Rodríguez; Alejandro Jiménez; Juan M Borreguero-León; Felipe Belmonte; Juan C Medina; Maria C Llimiñana; José M Ferrer-Agüero; José Ferreres; María L Mora; Santiago Lubillo; Manuel Sánchez; Ysamar Barrios; Antonio Sierra; José A Páramo
Journal:  Crit Care       Date:  2009-10-02       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.